Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?

Cancer accounted for almost ten million deaths worldwide in 2020. Metastasis, characterized by cancer cell invasion to other parts of the body, is the main cause of cancer morbidity and mortality. Therefore, understanding the molecular mechanisms of tumor formation and discovery of potential drug ta...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy Vol. 150; p. 113011
Main Authors: Mitra, Saikat, Sarker, Joyatry, Mojumder, Anik, Shibbir, Tasmim Bintae, Das, Rajib, Emran, Talha Bin, Tallei, Trina Ekawati, Nainu, Firzan, Alshahrani, Asma M., Chidambaram, Kumarappan, Simal-Gandara, Jesus
Format: Journal Article
Language:English
Published: France Elsevier Masson SAS 01-06-2022
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer accounted for almost ten million deaths worldwide in 2020. Metastasis, characterized by cancer cell invasion to other parts of the body, is the main cause of cancer morbidity and mortality. Therefore, understanding the molecular mechanisms of tumor formation and discovery of potential drug targets are of great importance. Gene editing techniques can be used to find novel drug targets and study molecular mechanisms. In this review, we describe how popular gene-editing methods such as CRISPR/Cas9, TALEN and ZFNs work, and, by comparing them, we demonstrate that CRISPR/Cas9 has superior efficiency and precision. We further provide an overview of the recent applications of CRISPR/Cas9 to cancer research, focusing on the most common cancers such as breast cancer, lung cancer, colorectal cancer, and prostate cancer. We describe how these applications will shape future research and treatment of cancer, and propose new ways to overcome current challenges. [Display omitted] •This review described how popular gene-editing methods work.•Findings demonstrated that CRISPR/Cas9 has superior efficiency and precision.•The recent applications of CRISPR/Cas9 to cancer research are also highlighted.•Described how these applications will shape future research and cancer treatment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2022.113011